Found: 224
Select item for more details and to access through your institution.
Multiple myeloma: 2024 update on diagnosis, risk‐stratification, and management.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 9, p. 1802, doi. 10.1002/ajh.27422
- By:
- Publication type:
- Article
Three‐dimensional telomere profiling predicts risk of progression in smoldering multiple myeloma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1532, doi. 10.1002/ajh.27364
- By:
- Publication type:
- Article
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL).
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. 1277, doi. 10.1002/ajh.26990
- By:
- Publication type:
- Article
Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 432, doi. 10.1002/ajh.26807
- By:
- Publication type:
- Article
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 413, doi. 10.1002/ajh.26806
- By:
- Publication type:
- Article
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 401, doi. 10.1002/ajh.26466
- By:
- Publication type:
- Article
Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. 1131, doi. 10.1002/ajh.26269
- By:
- Publication type:
- Article
Use of endpoints in multiple myeloma randomized controlled trials over the last 15 years: A systematic review.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 6, p. 690, doi. 10.1002/ajh.26166
- By:
- Publication type:
- Article
Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post‐autologous stem cell transplantation lenalidomide maintenance therapy.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. E157, doi. 10.1002/ajh.26125
- By:
- Publication type:
- Article
Refining amyloid complete hematological response: Quantitative serum free light chains superior to ratio.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 11, p. 1280, doi. 10.1002/ajh.25940
- By:
- Publication type:
- Article
Multiple myeloma: 2020 update on diagnosis, risk‐stratification and management.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 5, p. 548, doi. 10.1002/ajh.25791
- By:
- Publication type:
- Article
Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 5, p. 497, doi. 10.1002/ajh.25746
- By:
- Publication type:
- Article
Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. 4, doi. 10.1002/ajh.25657
- By:
- Publication type:
- Article
Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 5, p. E141, doi. 10.1002/ajh.25440
- By:
- Publication type:
- Article
Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 3, p. 306, doi. 10.1002/ajh.25365
- By:
- Publication type:
- Article
Utility and prognostic value of <sup>18</sup>F‐FDG positron emission tomography‐computed tomography scans in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 12, p. 1518, doi. 10.1002/ajh.25279
- By:
- Publication type:
- Article
Multiple myeloma: 2018 update on diagnosis, risk‐stratification, and management.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 8, p. 1091, doi. 10.1002/ajh.25117
- By:
- Publication type:
- Article
Time to plateau as a predictor of survival in newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. 889, doi. 10.1002/ajh.25113
- By:
- Publication type:
- Article
Reply to Castillo et al.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 3, p. E71, doi. 10.1002/ajh.25029
- By:
- Publication type:
- Article
Efficacy of VDT PACE‐like regimens in treatment of relapsed/refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. 179, doi. 10.1002/ajh.24954
- By:
- Publication type:
- Article
<italic>MYD88</italic> mutation status does not impact overall survival in Waldenström macroglobulinemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. 187, doi. 10.1002/ajh.24955
- By:
- Publication type:
- Article
Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL).
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. 17, doi. 10.1002/ajh.24919
- By:
- Publication type:
- Article
Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 11, p. 1146, doi. 10.1002/ajh.24883
- By:
- Publication type:
- Article
Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 7, p. 668, doi. 10.1002/ajh.24745
- By:
- Publication type:
- Article
Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosis.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 6, p. 549, doi. 10.1002/ajh.24723
- By:
- Publication type:
- Article
Hematology patient reported symptom screen to assess quality of life for AL amyloidosis.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 5, p. 435, doi. 10.1002/ajh.24676
- By:
- Publication type:
- Article
Ixazomib cardiotoxicity: A possible class effect of proteasome inhibitors.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 2, p. 220, doi. 10.1002/ajh.24608
- By:
- Publication type:
- Article
Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 1, p. 50, doi. 10.1002/ajh.24582
- By:
- Publication type:
- Article
N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 11, p. 1129, doi. 10.1002/ajh.24532
- By:
- Publication type:
- Article
Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 10, p. 984, doi. 10.1002/ajh.24453
- By:
- Publication type:
- Article
Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 7, p. 719, doi. 10.1002/ajh.24402
- By:
- Publication type:
- Article
Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 6, p. 585, doi. 10.1002/ajh.24356
- By:
- Publication type:
- Article
Clinical characteristics and outcomes in biclonal gammopathies.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 5, p. 473, doi. 10.1002/ajh.24319
- By:
- Publication type:
- Article
Myeloma today: Disease definitions and treatment advances.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 1, p. 90, doi. 10.1002/ajh.24236
- By:
- Publication type:
- Article
Outcomes of primary refractory multiple myeloma and the impact of novel therapies.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 11, p. 981, doi. 10.1002/ajh.24131
- By:
- Publication type:
- Article
Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myeloma.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 10, p. 888, doi. 10.1002/ajh.24107
- By:
- Publication type:
- Article
Soluble suppression of tumorigenicity 2 (s ST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-pro BNP and troponin T.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 6, p. 524, doi. 10.1002/ajh.24001
- By:
- Publication type:
- Article
Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 3, p. 181, doi. 10.1002/ajh.23898
- By:
- Publication type:
- Article
Multiple myeloma: 2014 Update on diagnosis, risk-stratification, and management.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 10, p. 999, doi. 10.1002/ajh.23810
- By:
- Publication type:
- Article
Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 11, p. 1051, doi. 10.1002/ajh.23827
- By:
- Publication type:
- Article
Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 3, p. 302, doi. 10.1002/ajh.23634
- By:
- Publication type:
- Article
Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 5, p. 375, doi. 10.1002/ajh.23413
- By:
- Publication type:
- Article
Multiple myeloma: 2013 update on diagnosis, risk-stratification, and management.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 3, p. 225, doi. 10.1002/ajh.23390
- By:
- Publication type:
- Article
Trends and outcomes of modern staging of solitary plasmacytoma of bone.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 7, p. 647, doi. 10.1002/ajh.23201
- By:
- Publication type:
- Article
Preventive strategies in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 5, p. 453, doi. 10.1002/ajh.23204
- By:
- Publication type:
- Article
Sorafenib, a multikinase inhibitor, is effective in vitro against non-hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 3, p. 277, doi. 10.1002/ajh.22263
- By:
- Publication type:
- Article
Multiple myeloma: 2012 update on diagnosis, risk-stratification, and management.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 1, p. 78, doi. 10.1002/ajh.22237
- By:
- Publication type:
- Article
Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: Results from a phase 2 trial.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 8, p. 640, doi. 10.1002/ajh.22053
- By:
- Publication type:
- Article
The definition of IgM multiple myeloma.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 8, p. 718, doi. 10.1002/ajh.22080
- By:
- Publication type:
- Article
High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, Africa.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 7, p. 554, doi. 10.1002/ajh.22040
- By:
- Publication type:
- Article